SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
申请人:Pfizer Inc.
公开号:US20170348313A1
公开(公告)日:2017-12-07
Compounds of the general formula):
processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.